Early experience with the Gore TAG thoracic branch endoprosthesis for treatment of acute aortic pathology

Early experience with the Gore TAG thoracic branch endoprosthesis for treatment of acute aortic pathology

The Gore TAG thoracic branch endoprosthesis (TBE) is the first Food and Drug Administration–approved device for zone 2 thoracic endovascular aortic repair, allowing for graft placement proximal to the left subclavian artery origin and maintaining vessel patency through a side branch. We describe our...

Full description

Bibliographic Details
Main Authors: Kathryn DiLosa, MD, MPH, Cara Pozolo, MD, Thomas Heafner, MD, Misty Humphries, MD, MAS, Mimmie Kwong, MD, MAS, Steven Maximus, MD
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:Journal of Vascular Surgery Cases and Innovative Techniques
Subjects:
Thoracic endovascular aortic repair
Branched endograft
Aortic transection
Online Access:http://www.sciencedirect.com/science/article/pii/S2468428723002721
Description
Summary:The Gore TAG thoracic branch endoprosthesis (TBE) is the first Food and Drug Administration–approved device for zone 2 thoracic endovascular aortic repair, allowing for graft placement proximal to the left subclavian artery origin and maintaining vessel patency through a side branch. We describe our experience with the Gore TBE device in 20 patients for acute indications, including blunt thoracic aortic injuries, complicated dissections, and ruptured aneurysms. Technical success, with exclusion of pathology and left subclavian patency, was 100% without major complications within 30 days. Our early Gore TBE device experience demonstrates safe use in acute aortic pathology without an increased risk of complications.
ISSN:2468-4287

Similar Items